NET PROFIT (x1000 DKK)
EMPLOYEES
Expres2ion Biotechnologies ApS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-61,130
|
-84,649
|
-29,733 |
Total assets |
50,210
|
91,017
|
106,379 |
Current assets |
45,138
|
89,369
|
104,669 |
Current liabilities |
7,314
|
21,148
|
6,600 |
Equity capital |
41,931
|
68,532
|
97,268 |
- share capital |
531
![]() |
531
![]() |
531 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
83.5%
|
75.3%
|
91.4% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
617.1%
|
422.6%
|
1585.9% |
Return on equity (ROE) |
-145.8%
|
-123.5%
|
-30.6% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.